FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945734080> ?p ?o ?g. }

• W2945734080 endingPage "35" @default.
• W2945734080 startingPage "26" @default.
• W2945734080 abstract "The role of adhesion G protein-coupled receptors (aGPCRs) in cancer has become increasingly evident in recent years. Yet, data supporting the contribution of this family of genes to hematological malignancies, particularly acute myeloid leukemia (AML) are limited. Here, we use publicly available genomic data to characterize the expression of the 33 aGPCRs in patients with AML and examine whether upregulation of these genes is associated with the clinical and molecular characteristics of patients. Upregulation in one or more of eight aGPCR genes (ADGRB1, ADGRC2, ADGRD1, ADGRE1, ADGRE2, ADGRE5, ADGRG1, and/or ADGRG3) was significantly associated with shorter overall survival (OS) (median OS: 11.8 vs 55.4 months; P < 0.0001). This was also significant in multivariate survival analysis (hazard ratio: 1.73; 95% confidence interval 1.11–2.69; P = 0.015) after adjusting for age, molecular risk status, and transplant status. High expression of the eight aGPCRs was significantly associated with older age (≥60; P = 0.011). Patients with high aGPCRs expression were more frequently classified in the poor molecular risk status group and less in the good risk status group compared with patients with low aGPCRs expression (31% vs 17% P = 0.049 and 14% vs 28% P = 0.027, respectively). Via Ingenuity Pathway Analysis, we identified the interleukin-8 signaling pathway among the most activated pathways in patients with high aGPCRs expression. Overall, our data suggest that particular aGPCRs are frequently upregulated in AML and associated with poor clinical outcome. Future functional and mechanistic analyses are needed to address the role of aGPCRs in AML. The role of adhesion G protein-coupled receptors (aGPCRs) in cancer has become increasingly evident in recent years. Yet, data supporting the contribution of this family of genes to hematological malignancies, particularly acute myeloid leukemia (AML) are limited. Here, we use publicly available genomic data to characterize the expression of the 33 aGPCRs in patients with AML and examine whether upregulation of these genes is associated with the clinical and molecular characteristics of patients. Upregulation in one or more of eight aGPCR genes (ADGRB1, ADGRC2, ADGRD1, ADGRE1, ADGRE2, ADGRE5, ADGRG1, and/or ADGRG3) was significantly associated with shorter overall survival (OS) (median OS: 11.8 vs 55.4 months; P < 0.0001). This was also significant in multivariate survival analysis (hazard ratio: 1.73; 95% confidence interval 1.11–2.69; P = 0.015) after adjusting for age, molecular risk status, and transplant status. High expression of the eight aGPCRs was significantly associated with older age (≥60; P = 0.011). Patients with high aGPCRs expression were more frequently classified in the poor molecular risk status group and less in the good risk status group compared with patients with low aGPCRs expression (31% vs 17% P = 0.049 and 14% vs 28% P = 0.027, respectively). Via Ingenuity Pathway Analysis, we identified the interleukin-8 signaling pathway among the most activated pathways in patients with high aGPCRs expression. Overall, our data suggest that particular aGPCRs are frequently upregulated in AML and associated with poor clinical outcome. Future functional and mechanistic analyses are needed to address the role of aGPCRs in AML." @default.
• W2945734080 created "2019-05-29" @default.
• W2945734080 creator A5003617778 @default.
• W2945734080 creator A5027341625 @default.
• W2945734080 creator A5054514509 @default.
• W2945734080 date "2019-10-01" @default.
• W2945734080 modified "2023-10-15" @default.
• W2945734080 title "Characterization of upregulated adhesion GPCRs in acute myeloid leukemia" @default.
• W2945734080 cites W1255676896 @default.
• W2945734080 cites W1986711353 @default.
• W2945734080 cites W1991509879 @default.
• W2945734080 cites W1994041743 @default.
• W2945734080 cites W2013636098 @default.
• W2945734080 cites W2014977509 @default.
• W2945734080 cites W2017365291 @default.
• W2945734080 cites W2022335352 @default.
• W2945734080 cites W2028645925 @default.
• W2945734080 cites W2032537701 @default.
• W2945734080 cites W2051852715 @default.
• W2945734080 cites W2101158706 @default.
• W2945734080 cites W2110502951 @default.
• W2945734080 cites W2110567472 @default.
• W2945734080 cites W2114843025 @default.
• W2945734080 cites W2129355608 @default.
• W2945734080 cites W2144246125 @default.
• W2945734080 cites W2149441684 @default.
• W2945734080 cites W2162825929 @default.
• W2945734080 cites W2181231475 @default.
• W2945734080 cites W2257905227 @default.
• W2945734080 cites W2322005850 @default.
• W2945734080 cites W2337848504 @default.
• W2945734080 cites W2417048285 @default.
• W2945734080 cites W2417787511 @default.
• W2945734080 cites W2551801949 @default.
• W2945734080 cites W2588374458 @default.
• W2945734080 cites W2600996432 @default.
• W2945734080 cites W2783337717 @default.
• W2945734080 cites W2794429211 @default.
• W2945734080 cites W2796332315 @default.
• W2945734080 cites W2808778039 @default.
• W2945734080 cites W3024656876 @default.
• W2945734080 doi "https://doi.org/10.1016/j.trsl.2019.05.004" @default.
• W2945734080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7473775" @default.
• W2945734080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31153896" @default.
• W2945734080 hasPublicationYear "2019" @default.
• W2945734080 type Work @default.
• W2945734080 sameAs 2945734080 @default.
• W2945734080 citedByCount "10" @default.
• W2945734080 countsByYear W29457340802019 @default.
• W2945734080 countsByYear W29457340802020 @default.
• W2945734080 countsByYear W29457340802022 @default.
• W2945734080 countsByYear W29457340802023 @default.
• W2945734080 crossrefType "journal-article" @default.
• W2945734080 hasAuthorship W2945734080A5003617778 @default.
• W2945734080 hasAuthorship W2945734080A5027341625 @default.
• W2945734080 hasAuthorship W2945734080A5054514509 @default.
• W2945734080 hasBestOaLocation W29457340802 @default.
• W2945734080 hasConcept C104317684 @default.
• W2945734080 hasConcept C126322002 @default.
• W2945734080 hasConcept C127561419 @default.
• W2945734080 hasConcept C143998085 @default.
• W2945734080 hasConcept C207103383 @default.
• W2945734080 hasConcept C2778729363 @default.
• W2945734080 hasConcept C44249647 @default.
• W2945734080 hasConcept C54355233 @default.
• W2945734080 hasConcept C60644358 @default.
• W2945734080 hasConcept C71924100 @default.
• W2945734080 hasConcept C86803240 @default.
• W2945734080 hasConceptScore W2945734080C104317684 @default.
• W2945734080 hasConceptScore W2945734080C126322002 @default.
• W2945734080 hasConceptScore W2945734080C127561419 @default.
• W2945734080 hasConceptScore W2945734080C143998085 @default.
• W2945734080 hasConceptScore W2945734080C207103383 @default.
• W2945734080 hasConceptScore W2945734080C2778729363 @default.
• W2945734080 hasConceptScore W2945734080C44249647 @default.
• W2945734080 hasConceptScore W2945734080C54355233 @default.
• W2945734080 hasConceptScore W2945734080C60644358 @default.
• W2945734080 hasConceptScore W2945734080C71924100 @default.
• W2945734080 hasConceptScore W2945734080C86803240 @default.
• W2945734080 hasFunder F4320332161 @default.
• W2945734080 hasLocation W29457340801 @default.
• W2945734080 hasLocation W29457340802 @default.
• W2945734080 hasLocation W29457340803 @default.
• W2945734080 hasOpenAccess W2945734080 @default.
• W2945734080 hasPrimaryLocation W29457340801 @default.
• W2945734080 hasRelatedWork W2090763189 @default.
• W2945734080 hasRelatedWork W2154948599 @default.
• W2945734080 hasRelatedWork W2516062397 @default.
• W2945734080 hasRelatedWork W2792916732 @default.
• W2945734080 hasRelatedWork W2793335702 @default.
• W2945734080 hasRelatedWork W2913113213 @default.
• W2945734080 hasRelatedWork W2914671834 @default.
• W2945734080 hasRelatedWork W3114266572 @default.
• W2945734080 hasRelatedWork W4210646467 @default.
• W2945734080 hasRelatedWork W4254083861 @default.
• W2945734080 hasVolume "212" @default.
• W2945734080 isParatext "false" @default.
• W2945734080 isRetracted "false" @default.

• next